Aspiriant LLC’s Vanguard Intermediate-Term Bond ETF BIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,050
Closed -$343K 93
2017
Q3
$343K Buy
+4,050
New +$344K 0.03% 154

Other funds holding BIV

Aspiriant LLC's BIV Position: Q4 2017 in Review

Aspiriant LLC sold out of Vanguard Intermediate-Term Bond ETF (BIV) in Q4 2017, closing a stake of 4,050 shares — an estimated $343K sold.

Aspiriant LLC first reported a position in BIV in Q3 2017 and held it in 1 quarter. The position peaked at $343K in Q3 2017. 406 funds tracked by Wall St. Rank hold BIV as of Q4 2017.

  • Aspiriant LLC reported no remaining Vanguard Intermediate-Term Bond ETF position as of Q4 2017 after selling out during the quarter.
  • Aspiriant LLC sold 4,050 Vanguard Intermediate-Term Bond ETF shares in Q4 2017, an estimated $343K.
  • Aspiriant LLC first reported a position in Vanguard Intermediate-Term Bond ETF in Q3 2017 and held it in 1 quarter.
  • Aspiriant LLC's Vanguard Intermediate-Term Bond ETF position peaked at $343K in Q3 2017.
  • 406 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Bond ETF as of Q4 2017.

Based on Aspiriant LLC's 13F filing for Q4 2017, filed 31 Jan 2018.